Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease

• Published in: Brain (London, England : 1878) Vol. 145; no. 2; pp. 713 - 728
• Main Authors: Strom, Amelia, Iaccarino, Leonardo, Edwards, Lauren, Lesman-Segev, Orit H, Soleimani-Meigooni, David N, Pham, Julie, Baker, Suzanne L, Landau, Susan M, Jagust, William J, Miller, Bruce L, Rosen, Howard J, Gorno-Tempini, Maria Luisa, Rabinovici, Gil D, La Joie, Renaud
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 18.04.2022
• Subjects: Alzheimer Disease - diagnostic imaging; Alzheimer Disease - genetics; Amyloid - metabolism; Apolipoprotein E4 - genetics; Atrophy; Brain - metabolism; Cognitive Dysfunction - diagnostic imaging; Cognitive Dysfunction - genetics; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Original; Positron-Emission Tomography - methods; tau Proteins - metabolism; tau; amyloid; Alzheimer’s disease; hypometabolism; PET
• ISSN: 0006-8950; 1460-2156
• DOI: 10.1093/brain/awab294

Posterior cortical hypometabolism measured with 18F-fluorodeoxyglucose (FDG)-PET is a well-known marker of Alzheimer's disease-related neurodegeneration, but its associations with underlying neuropathological processes are unclear. We assessed cross-sectionally the relative contributions of three potential mechanisms causing hypometabolism in the retrosplenial and inferior parietal cortices: local molecular (amyloid and tau) pathology and atrophy, distant factors including contributions from the degenerating medial temporal lobe or molecular pathology in functionally connected regions, and the presence of the apolipoprotein E (APOE) ε4 allele. Two hundred and thirty-two amyloid-positive cognitively impaired patients from two cohorts [University of California, San Francisco (UCSF), and Alzheimer's Disease Neuroimaging Initiative (ADNI)] underwent MRI and PET with FDG, amyloid-PET using 11C-Pittsburgh Compound-B, 18F-florbetapir or 18F-florbetaben, and 18F-flortaucipir tau-PET in 1 year. Standard uptake value ratios (SUVRs) were calculated using tracer-specific reference regions. Regression analyses were run within cohorts to identify variables associated with retrosplenial or inferior parietal FDG standard uptake value ratios. On average, ADNI patients were older and were less impaired than the UCSF patients. Regional patterns of hypometabolism were similar between cohorts, although there were cohort differences in regional grey matter atrophy. Local cortical thickness and tau-PET (but not amyloid-PET) were independently associated with both retrosplenial and inferior parietal FDG SUVRs (ΔR2 = 0.09 to 0.21) across cohorts in models that also included age and disease severity (local model). Including medial temporal lobe volume improved the retrosplenial FDG model in the ADNI cohort (ΔR2 = 0.04, P = 0.008) but not for the UCSF (ΔR2 < 0.01, P = 0.52), and did not improve the inferior parietal models (ΔR2 < 0.01, P > 0.37). Interaction analyses revealed that medial temporal volume was more strongly associated with retrosplenial FDG SUVRs at earlier disease stages (P = 0.06 in UCSF, P = 0.046 in ADNI). Exploratory analyses across the cortex confirmed overall associations between hypometabolism and local tau pathology and thickness and revealed associations between medial temporal degeneration and hypometabolism in retrosplenial, orbitofrontal and anterior cingulate cortices. Finally, our data did not support hypotheses of a detrimental effect of pathology in connected regions or of an effect of the APOE ε4 allele in impaired participants. Overall, in two independent groups of patients at symptomatic stages of Alzheimer's disease, cortical hypometabolism mainly reflected structural neurodegeneration and tau, but not amyloid, pathology.